You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 298 No. 10, September 12, 2007 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on Web of Science (1)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Cardiovascular System, Other
 •Pediatrics
 •Pediatrics, Other
 •Quality of Life
 •Statistics and Research Methods
 •Randomized Controlled Trial
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Importance of Randomized Controlled Trials in Pediatric Cardiology

Samuel S. Gidding, MD

JAMA. 2007;298:1214-1216.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Experience with randomized controlled clinical trials in pediatric cardiology is limited. Perhaps the most cited article in the field had a sample size of 1, a baby with transposition of the great arteries who successfully underwent balloon dilation of a patent foramen ovale.1 When this procedure was found to improve survival from a median of less than a week to several years, the immediate challenge to clinicians was not to replicate the finding by a randomized trial but to determine how best to manage a living child with an oxygen saturation of 60% to 70% and persistent complex anatomical defects.

Within 25 years and incorporating many technical innovations into diagnosis and management, more than 95% of children born with this defect survived an arterial switch procedure with little morbidity until adulthood.2-3 Along the path to these results, many treatment centers simply converted from performing the conventional . . . [Full Text of this Article]

Author Affiliations: Nemours Cardiac Center, A. I. duPont Hospital for Children, Wilmington, Delaware; Jefferson Medical College, Philadelphia, Pennsylvania.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Carvedilol for Children and Adolescents With Heart Failure: A Randomized Controlled Trial
Robert E. Shaddy, Mark M. Boucek, Daphne T. Hsu, Robert J. Boucek, Charles E. Canter, Lynn Mahony, Robert D. Ross, Elfriede Pahl, Elizabeth D. Blume, Debra A. Dodd, David N. Rosenthal, Jeri Burr, Bernie LaSalle, Richard Holubkov, Mary Ann Lukas, Lloyd Y. Tani, and For the Pediatric Carvedilol Study Group
JAMA. 2007;298(10):1171-1179.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.